<?xml version="1.0" encoding="UTF-8"?>
<project>
  <language>en</language>
  <availableLanguages>en</availableLanguages>
  <rcn>240740</rcn>
  <id>101081290</id>
  <acronym>RIFTVAX</acronym>
  <teaser>Initial funding was provided to the Coalition for Epidemic Preparedness Innovations (CEPI) in 2019 which was used to support preclinical and clinical development of Rift Valley fever (RVF) and Chikungunya (Chik) vaccines respectively. This funding was provided to applicants as...</teaser>
  <objective>Initial funding was provided to the Coalition for Epidemic Preparedness Innovations (CEPI) in 2019 which was used to support preclinical and clinical development of Rift Valley fever (RVF) and Chikungunya (Chik) vaccines respectively. This funding was provided to applicants as a joint effort between CEPI and the Horizon 2020 programme, under the CEPI Call for Proposals CfP3i. 
Whilst previous funding has led to the development of pre-licensure Chik vaccines, development of RVF vaccines is at a much earlier stage. Hence, this current application seeks to leverage a further 35M from Horizon Europe, which will be supplemented with 15M from CEPI, making a pool of 50M, which will be used to fund clinical development of RVF vaccine projects under the CEPI follow-up Call for Proposals CfP3ii.
It is envisaged that applicants for the CfP3ii funding will have already developed a manufacturing plan and that all preclinical studies have been completed (with the possible exception of Development and Reproductive Toxicology (DART) studies). Applicants will propose Phase I/II trials in endemic regions for vaccines which are in accordance with the WHO Target Product Profile (https://www.who.int/docs/default-source/blue-print/call-for-comments/tpp-rift-valley-fever-vaccines-draft3-0pc.pdf?sfvrsn=f2f3b314_2) for RVF vaccines.
Awards will usually have a 36-month duration and will be administered by the CEPI secretariat.</objective>
  <title>Clinical development of Rift Valley fever vaccines in endemic regions</title>
  <totalCost>50000000</totalCost>
  <ecMaxContribution>35000000</ecMaxContribution>
  <startDate>2022-08-01</startDate>
  <endDate>2026-07-31</endDate>
  <ecSignatureDate>2022-07-14</ecSignatureDate>
  <duration>48</duration>
  <status>SIGNED</status>
  <keywords>Vaccine, Rift, Clinical</keywords>
  <identifiers>
    <grantDoi>10.3030/101081290</grantDoi>
  </identifiers>
  <validation>
    <euroSciVoc>false</euroSciVoc>
  </validation>
  <sourceUpdateDate>2025-01-03 10:47:16</sourceUpdateDate>
  <contentCreationDate>2022-09-04 12:40:53</contentCreationDate>
  <contentUpdateDate>2023-03-10 21:50:57</contentUpdateDate>
  <lastUpdateDate>2025-09-19 14:48:45</lastUpdateDate>
  <relations>
    <associations>
      <article source="editorial" type="relatedArticle">
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <rcn>437868</rcn>
        <id>437868-vaccines-against-rift-valley-fever</id>
        <title>Vaccines against Rift Valley fever</title>
        <contentUpdateDate>2022-12-07 17:34:03</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/projectDescription</code>
              <title>Project description</title>
              <description>Article: description of linked project written by editorial team</description>
              <displayCode>/Project description</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/editorial</code>
              <title>CORDIS Editorial</title>
              <description>Written by CORDIS</description>
              <displayCode>/CORDIS Editorial</displayCode>
            </category>
          </categories>
        </relations>
      </article>
      <call source="corda" type="relatedMasterCall">
        <rcn>55643</rcn>
        <title>HORIZON-HLTH-2021-CEPI-10-IBA</title>
        <identifier>HORIZON-HLTH-2021-CEPI-10-IBA</identifier>
      </call>
      <call source="corda" type="relatedSubCall">
        <rcn>55643</rcn>
        <title>HORIZON-HLTH-2021-CEPI-10-IBA</title>
        <identifier>HORIZON-HLTH-2021-CEPI-10-IBA</identifier>
      </call>
      <organization netEcContribution="35000000" totalCost="50000000" source="corda" order="1" ecContribution="35000000" terminated="false" sme="false" type="coordinator">
        <availableLanguages>en</availableLanguages>
        <rcn>1960246</rcn>
        <id>903459068</id>
        <legalName>COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS</legalName>
        <shortName>CEPI</shortName>
        <address>
          <street>SKOYEN ATRIUM ASKEKROKEN 11</street>
          <city>Oslo</city>
          <postalCode>0277</postalCode>
          <country>NO</country>
          <geolocation>59.9221933,10.6827199</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/REC</code>
              <title>Research Organisations</title>
              <displayCode>/Research Organisations</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Norway</name>
              <rcn>392333864</rcn>
              <nutsCode>NO</nutsCode>
              <euCode>NO</euCode>
              <isoCode>NO</isoCode>
            </region>
            <region type="relatedRegion">
              <name>Norway</name>
              <rcn>392333864</rcn>
              <nutsCode>NO</nutsCode>
              <euCode>NO</euCode>
              <isoCode>NO</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <programme type="relatedLegalBasis" source="corda" uniqueProgrammePart="true">
        <availableLanguages>en</availableLanguages>
        <rcn>705741</rcn>
        <id>HORIZON.2.1</id>
        <code>HORIZON.2.1</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <pga>HORIZON.2.1</pga>
        <title>Health</title>
        <parent>
          <programme>
            <rcn>705740</rcn>
            <code>HORIZON.2</code>
            <parent>
              <programme>
                <rcn>705725</rcn>
                <code>HORIZON</code>
              </programme>
            </parent>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/legalbasis</code>
              <title>Legal Basis</title>
              <description>Programme: Legal basis for research funding</description>
              <displayCode>/Legal Basis</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <programme type="relatedTopic" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>706801</rcn>
        <id>HORIZON_HORIZON-HLTH-2021-CEPI-10-01-IBA</id>
        <code>HORIZON-HLTH-2021-CEPI-10-01-IBA</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <title>CEPI 3 - Contribution to the Coalition for Epidemics Preparedness Initiative</title>
        <parent>
          <programme>
            <rcn>20300</rcn>
            <code>HORIZON-Topics</code>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/topic</code>
              <title>Topic</title>
              <description>Programme: Part of the Commission work programme implementing legal basis</description>
              <displayCode>/Topic</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450332</code>
              <title>Clinical research</title>
              <displayCode>/Clinical research</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43453813</code>
              <title>Interventional clinical trials</title>
              <displayCode>/Interventional clinical trials</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450302</code>
              <title>Clinical development, Phase I</title>
              <displayCode>/Clinical development, Phase I</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450314</code>
              <title>Clinical information</title>
              <displayCode>/Clinical information</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/44368887</code>
              <title>Viral Haemorrhagic Fevers</title>
              <displayCode>/Viral Haemorrhagic Fevers</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43458724</code>
              <title>Viruses</title>
              <displayCode>/Viruses</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450305</code>
              <title>Clinical development, Phase II</title>
              <displayCode>/Clinical development, Phase II</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43451518</code>
              <title>Emergent diseases</title>
              <displayCode>/Emergent diseases</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43451521</code>
              <title>Emerging Epidemics</title>
              <displayCode>/Emerging Epidemics</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43458634</code>
              <title>Vaccines</title>
              <displayCode>/Vaccines</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450299</code>
              <title>Clinical data</title>
              <displayCode>/Clinical data</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43452784</code>
              <title>Global health</title>
              <displayCode>/Global health</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43456168</code>
              <title>Primary prevention</title>
              <displayCode>/Primary prevention</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43455742</code>
              <title>Pharmacokinetics</title>
              <displayCode>/Pharmacokinetics</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450338</code>
              <title>Clinical trials</title>
              <displayCode>/Clinical trials</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43457107</code>
              <title>Secondary prevention</title>
              <displayCode>/Secondary prevention</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450218</code>
              <title>Chikingunya</title>
              <displayCode>/Chikingunya</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450308</code>
              <title>Clinical development, Phase III</title>
              <displayCode>/Clinical development, Phase III</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43455727</code>
              <title>Pharmaceutical development</title>
              <displayCode>/Pharmaceutical development</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43455730</code>
              <title>Pharmacodynamics</title>
              <displayCode>/Pharmacodynamics</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <programme type="relatedLegalBasis" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>705745</rcn>
        <id>HORIZON.2.1.4</id>
        <code>HORIZON.2.1.4</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <pga>HORIZON.2.1.4</pga>
        <title>Infectious Diseases, including poverty-related and neglected diseases</title>
        <parent>
          <programme>
            <rcn>705741</rcn>
            <code>HORIZON.2.1</code>
            <parent>
              <programme>
                <rcn>705740</rcn>
                <code>HORIZON.2</code>
                <parent>
                  <programme>
                    <rcn>705725</rcn>
                    <code>HORIZON</code>
                  </programme>
                </parent>
              </programme>
            </parent>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/legalbasis</code>
              <title>Legal Basis</title>
              <description>Programme: Legal basis for research funding</description>
              <displayCode>/Legal Basis</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <result type="relatedResult" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>1102532</rcn>
        <id>101081290_5_DELIVHORIZON</id>
        <title>JMAG report - 1</title>
        <description>Mo 12: Summary report of JMAG feedback for each funded project</description>
        <sourceUpdateDate>2024-06-08 11:34:04</sourceUpdateDate>
        <contentUpdateDate>2024-06-10 10:03:52</contentUpdateDate>
        <relations>
          <associations>
            <webLink source="corda" type="projectDeliverable">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <id>29fd4945dc35332e6424c3c29238b190</id>
              <physUrl>https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e50a7deca0&amp;appId=PPGMS</physUrl>
              <defaultLanguage>en</defaultLanguage>
            </webLink>
          </associations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/deliverable</code>
              <title>Project deliverable</title>
              <description>Result: Project deliverables</description>
              <displayCode>/Project deliverable</displayCode>
            </category>
            <category classification="deliverableType" type="isDeliveredAs">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/R</code>
              <title>Documents, reports</title>
              <displayCode>/Documents, reports</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
      <result type="relatedResult" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>1110422</rcn>
        <id>101081290_PSHORIZON</id>
        <title>Periodic Reporting for period 1 - RIFTVAX (Clinical development of Rift Valley fever vaccines in endemic regions)</title>
        <description>periodic</description>
        <teaser>Spread by a virus of the same name, Rift Valley fever (RVF) is transmitted by different species of mosquitoes (Aedes, Culex, Anopheles, and Mansonia) as well as blood feeding flies, often driven by climatic changes across Africa and parts of the Arabian Peninsula. It most...</teaser>
        <sourceUpdateDate>2024-06-12 20:00:32</sourceUpdateDate>
        <contentUpdateDate>2024-06-13 17:18:58</contentUpdateDate>
        <relations>
          <associations>
            <webItem type="relatedResultAttachment" source="corda">
              <language>en</language>
              <availableLanguages>en,any</availableLanguages>
              <uri>/docs/results/horizon/101081/101081290_PS/screenshot-2024-03-25-140717.png</uri>
              <alternativeText>CfP launch press release</alternativeText>
              <mimetype>image/png</mimetype>
              <size>182272</size>
            </webItem>
          </associations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/pubsum</code>
              <title>Report Summary</title>
              <description>Result: Publishable summary (FP7 SESAM) and Summary for publication (H2020 SyGMa)</description>
              <displayCode>/Report Summary</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
    </associations>
    <categories>
      <category classification="collection" type="belongsTo">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/project</code>
        <title>Project</title>
        <description>Project factsheets</description>
        <displayCode>/Project</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/21/35/159/653/1439</code>
        <title>vaccines</title>
        <displayCode>/medical and health sciences/basic medicine/pharmacology and pharmacy/pharmaceutical drugs/vaccines</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/21/35/147</code>
        <title>toxicology</title>
        <displayCode>/medical and health sciences/basic medicine/toxicology</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/digitalAgenda</code>
        <title>Digital agenda</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development of digital technologies and the digitisation of the economy and society (known as ‘Digital transition’).</description>
        <displayCode>/Digital agenda</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/cleanAir</code>
        <title>Clean air</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to the clean air policy (National Emission Ceiling Directive) aiming to improve ambient air quality and tackle air pollution, to protect the environment and human health.</description>
        <displayCode>/Clean air</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/ai</code>
        <title>Artificial intelligence</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development and deployment of AI-based technologies and solutions. Projects that develop AI-tools as part of their research method are included</description>
        <displayCode>/Artificial intelligence</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/climate</code>
        <title>Climate action</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to both mitigating climate change (e.g., contributions to the reduction of greenhouse gas emissions) and adapting to climate change by building resilience (e.g., regarding floods, droughts, spatial planning and better governance, adaptation to changing climate in value chains, etc.).</description>
        <displayCode>/Climate action</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/biodiversity</code>
        <title>Biodiversity</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to Europe’s biodiversity’s path to recovery including species protection, ecosystem conservation, and habitat rehabilitation, all essential for resilience in climate adaptation and addressing ecosystem services but also environmental crime and the health-environment connection.</description>
        <displayCode>/Biodiversity</displayCode>
      </category>
      <category classification="projectFundingSchemeCategory" type="relatedProjectFundingSchemeCategory">
        <language>en</language>
        <availableLanguages>en</availableLanguages>
        <code>/HORIZON-COFUND</code>
        <title>HORIZON Programme Cofund Actions</title>
        <description>HORIZON Programme Cofund Actions</description>
        <displayCode>/HORIZON Programme Cofund Actions</displayCode>
      </category>
      <category classification="source" type="isProvidedBy">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/corda</code>
        <title>CORDA</title>
        <description>RTD research data warehouse</description>
        <displayCode>/CORDA</displayCode>
      </category>
    </categories>
  </relations>
</project>